Atlas Trials

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

Clinical trial NCT06273020 · UNKNOWN

Trial details

NCT number
NCT06273020
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Ischemic Stroke, AcuteDiabetes Mellitus, Type 2Blood Brain Barrier
Start date
2022-11-17
Primary completion
2024-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.